Sanam Loghavi, Associate Professor

Sanam Loghavi is an Associate Professor of Pathology and Laboratory Medicine at the Department of Hematopathology at MD Anderson Cancer Center. She completed her medical school training at Azad University in Tehran, Iran, followed by residency training in anatomic and clinical pathology at Cedars Sinai Medical Center in Los Angeles, California. She pursued further fellowship training in surgical pathology, followed by hematopathology and molecular pathology at MD Anderson Cancer Center. She is Board-certified in hematopathology and molecular pathology and specializes in hematologic malignancies, in particular myeloid neoplasms. Her research interests include molecular risk stratification of hematologic neoplasms and measurable residual disease detection by flow cytometry and next generation sequencing in hematologic malignancies. She is the Medical Director of the ECOG/ACRIN Leukemia Bank at the Central Biorepository and Pathology Facility at MD Anderson. She has authored more than 180 peer-reviewed publications focused on hematologic neoplasms and is a co-investigator on several national and internationally-run clinical trials for hematologic malignancies. She serves on various committees including the HPATH Committee of the College of American Pathologists and the Education and Outreach Committees for International Clinical Cytometry Society.
Financial relationships
-
Attribution:SelfType of financial relationship:StockIneligible company:AbbvieDate added:01/17/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:GuidepointDate added:01/17/2023Relationship end date:04/21/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:QualWorldDate added:01/17/2023Relationship end date:05/12/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:GLGDate added:01/17/2023Relationship end date:08/30/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AbbvieDate added:01/17/2023Relationship end date:08/08/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Daiichi SankyoDate added:01/17/2023Relationship end date:09/26/2022
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:CarisDate added:01/17/2023Relationship end date:11/04/2022
-
Attribution:SelfType of financial relationship:TravelIneligible company:Mission BioDate added:01/17/2023Relationship end date:11/03/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:OncLiveDate added:01/17/2023Relationship end date:12/12/2022